SIRPA and cancer: Many studies have reported that tumors evade macrophage phagocytosis and immune surveillance by activating the inhibitory signal via the ligation of SIRPα (which is expressed on phagocytes as a receptor) with CD47 (which is highly expressed on cancer cells as a ligand) (Zhao et al., 2018).